Skip to main content
2026 CRT Conference Main banner

CRT 2026

Coronary

Session:: Complex PCI | Monday Morning [Non-CME]

Panel Discussion | HIGH-RISK PCI | LM

Monday, March 9, 2026
10:43 AM - 11:00 AM EST
Location: CRT Center Stage

    Moderator(s)

  • Jeffrey W. Moses, MD, FSCAI

    John and Myrna Daniels Professor of Cardiology
    Columbia University Medical Center
    New York, New York, United States

    Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)

  • David G. Rizik, MD, MSCAI, FACC

    Health System Chief of Cardiovascular Service Line, Physician Executive Community Cardiovascular Research
    Banner University Medicine, Scottsdale Arizona
    Scottsdale, Arizona, United States

    Disclosure(s): No financial relationships to disclose

  • Alfredo E. Rodriguez, MD,PhD

    Director Cardiac Unit
    Otamendi Hospital
    CABA, Buenos Aires, Argentina

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Bassem Chehab, MD

    Director - Structural Heart Program
    Ascension Via Christi
    Wichita, Kansas, United States

    Disclosure(s): No financial relationships to disclose

  • Debabrata Dash, MD, DM, FICC, FSCAI, FAPHA, , FACC, FESC

    Consultant Interventional Cardiologist
    Aster Hospital, Al Mankhool Dubai, UAE
    Dubai, Dubai, United Arab Emirates

    Disclosure(s): No financial relationships to disclose

  • Fady Iskander, MD MSc

    Interventional cardiologist
    Kaiser permanente - CPMG
    Denver, Colorado, United States

    Disclosure(s): No financial relationships to disclose

  • Hani Jneid, MD

    Hani Jneid, MD, FACC, FAHA, FSCAI John Sealy Distinguished Centennial Chair in Cardiology Professor & Chief, Division of Cardiology Department of Internal Medicine Medical Director, Cardiovascular Service Line University of Texas Medical Branch
    University of Texas Medical Branch
    Galveston, Texas, United States

    Disclosure(s): No financial relationships to disclose

  • ML

    Michael S. Lee, MD, FACC, FSCAI

    Chief of Cardiology, Interventional Cardiologist
    Griffin Hospital
    LOS ANGELES, California, United States

    Disclosure(s): No financial relationships to disclose

  • Marco V. Wainstein, MD, PhD

    Associate Professor
    School of Medicine, Federal University of Rio Grande do Sul
    Porto Alegre, Brazil

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Jeffrey W. Moses, MD, FSCAI: Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
David G. Rizik, MD, MSCAI, FACC: No financial relationships to disclose
Bassem Chehab, MD: No financial relationships to disclose
Debabrata Dash, MD, DM, FICC, FSCAI, FAPHA, , FACC, FESC: No financial relationships to disclose
Fady Iskander, MD MSc: No financial relationships to disclose
Hani Jneid, MD: No financial relationships to disclose
Michael S. Lee, MD, FACC, FSCAI: No financial relationships to disclose
Marco V. Wainstein, MD, PhD: No financial relationships to disclose